Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan

Journal of Rheumatology - Canada
doi 10.3899/jrheum.080791
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Journal of Rheumatology

Related search

Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

O1-3-1Safety and Effectiveness of Pembrolizumab Monotherapy in NSCLC: Interim Analysis of Japan Postmarketing Surveillance

Annals of Oncology
MedicineOncologyHematology
2018English

Editorial to the Postmarketing Surveillance on the Clinical Use of Edoxaban in Patients With Nonvalvular Atrial Fibrillation (ETNA-AF Japan): One-Year Safety and Effectiveness Analyses

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2020English

Safety and Efficacy of Mogamulizumab in Patients With Adult T-Cell Leukemia-Lymphoma in Japan: Interim Results of Postmarketing All-Case Surveillance

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Effectiveness, Safety, and Methotrexate Dose-Tapering Pattern Over Two Years of Treatment With Adalimumab and ≥12 Mg/Week Methotrexate for Early Rheumatoid Arthritis: Results of the HAWK Postmarketing Surveillance Study in Japan

Modern Rheumatology
MedicineRheumatology
2019English

TAS-102 Safety in Metastatic Colorectal Cancer: Results From the First Postmarketing Surveillance Study

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Cardiovascular Safety of COX-2 Inhibition: Time to Inform Systems of Postmarketing Surveillance?

Therapy
2005English

Safety and Effectiveness of Sorafenib in Japanese Patients With Hepatocellular Carcinoma in Daily Medical Practice: Interim Analysis of a Prospective Postmarketing All-Patient Surveillance Study

Journal of Gastroenterology
Gastroenterology
2016English

Postmarketing Surveillance of Adverse Drug Reactions

BMJ
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy